Gabon vs Venezuela, Bolivarian Republic of: Immunization, Hib3
Immunization, Hib3 over time
- Gabon
- Venezuela, Bolivarian Republic of
How they compare
Venezuela, Bolivarian Republic of currently reports 62.0% against 61.0% in Gabon, a difference of 1.0%.
The two have swapped places 4 times across 15 shared years of data; in 2010 it was Venezuela, Bolivarian Republic of ahead.
Gabon ranks 181st and Venezuela, Bolivarian Republic of ranks 180th of 191 countries.
Across the 2 decades both report, Gabon averaged higher in 1 and Venezuela, Bolivarian Republic of in 1.
Head to head by decade
| Decade | Gabon | Venezuela, Bolivarian Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 74.3% | 75.8% | 1.5% | Venezuela, Bolivarian Republic of |
| 2020s | 65.8% | 53.8% | 12.0% | Gabon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Gabon or Venezuela, Bolivarian Republic of?
- Venezuela, Bolivarian Republic of, at 62.0% against 61.0% in Gabon as of 2024.
- What is the difference in immunization, hib3 between Gabon and Venezuela, Bolivarian Republic of?
- 1.0%, with Venezuela, Bolivarian Republic of ahead.
- How many years of comparable data are there for Gabon and Venezuela, Bolivarian Republic of?
- 15 years are reported by both, from 2010 to 2024.
- How do Gabon and Venezuela, Bolivarian Republic of rank globally for immunization, hib3?
- Gabon ranks 181st and Venezuela, Bolivarian Republic of ranks 180th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.